Dignover
Brand names,
Dignover
Analogs
Dignover
Brand Names Mixture
- Tarka (trandolapril + verapamil hydrochloride)
Dignover
Chemical_Formula
C27H38N2O4
Dignover
RX_link
http://www.rxlist.com/cgi/generic/verapsr.htm
Dignover
fda sheet
Dignover
msds (material safety sheet)
Dignover
Synthesis Reference
Dengel, U.S. Pat. 3,261,859 (1966)
Dignover
Molecular Weight
454.602 g/mol
Dignover
Melting Point
< 25 oC
Dignover
H2O Solubility
4.47 mg/L
Dignover
State
Liquid
Dignover
LogP
5.931
Dignover
Dosage Forms
Capsule (sustained-release); Liquid; Solution; Tablet; Tablet (extended-release)
Dignover
Indication
For the treatment of hypertension and angina.
Dignover
Pharmacology
Verapamil, a class IV antiarrhythmic agent, is used as a calcium-channel blocking (CCB) agent for the treatment of angina, hypertension, and for supraventricular tachyarrhythmias.
Dignover
Absorption
90%
Dignover
side effects and Toxicity
LD50=8 mg/kg (i.v. in mice)
Dignover
Patient Information
Verapamil HCl is known as a calcium channel blocker. It is taken to treat high blood pressure, to relieve some
chest pains in patients with angina, or to treat some problems with heart rhythms. Verapamil has several drug
interactions, make sure your physician and pharmacist known all the medicines you are taking so they may properly
advise you. Verapamil HCl is excreted in breast milk. It may be necessary to change therapy or provide an alternate
to breast milk. The most common side effect is constipation. This may be relieved with dietary modification (more
fiber) or laxatives. Sustained release tablets should be taken with food. They should not be broken or crushed. Doses
may need some adjustment, make sure to have your condition monitored regularly.
Dignover
Organisms Affected
Humans and other mammals